Developing Next-Generation Organ and Tissue Transplant Solutions
INDUSTRY: MedTech / Regenerative Medicine / AI
NUMBER OF EMPLOYEES: 6
MARKET SIZE: $6.4 B WW sales
USE OF FUNDS: FDA verification and validation studies, clinical study design, manufacturing scale-up, patent work, pipeline expansion
At BMI OrganBank, DiMarzio leads a team of experts in perfusion technology that will advance organ transplantation and novel ex vivo laboratory research - both projects have the potential to save thousands of lives. She guides partnerships of BMI OrganBank with organizations such as the Wake Forest Institute for Regenerative Medicine (WFIRM), Lawrence Livermore National Laboratory (LLNL), Duke Ex-Vivo Organ Laboratory (DEVOL), Cystic Fibrosis Foundation, and RegenMed Development Organization (ReMDO). Additionally, DiMarzio also serves on the Executive Leadership Council Board of ReMDO. During her time at BMI OrganBank, DiMarzio has led successful negotiations with the US FDA, gaining FDA EUA status for BMI OrganBank's SuppleVent™ device for use during the COVID-19 pandemic. DiMarzio's current endeavor is guiding OrganBankTM technology - a proprietary organ preservation system - through the FDA clearance project.
As noted, DiMarzio also serves as CEO for IHC, a precision engineering business that serves the bio-medical, aerospace, and automotive sectors, providing microscopically thin and diamond-like hard surface film modifications that vastly improve equipment performance and durability.
DiMarzio has relevant business experience in sales and marketing as well as quality control, can help to guide business owners on the difficult road toward increased efficiency and productivity, and has an in-depth familiarity with human capital development. DiMarzio is known for her attention to detail, her equal commitment to her company, team, and stakeholders, and her remarkable ability to elicit 'personal bests' from each member of the high-performing teams under her charge.
When DiMarzio is not making a difference by managing cutting-edge projects at these two innovative companies based in North Carolina, she engages deeply with her local church and community, coaches female sports for the local schools, and is significantly involved in global outreach programs to provide for those in need.
Wide range of leadership positions in the commercialization and development of drugs and devices. Notable career experiences include planning launches for novel devices and drugs, establishing research, development and commercial partnerships, and overseeing payor strategy and patient support services for a multi-billion-dollar product franchise. Co-invented and led the development of a diagnostic device now under ongoing approval by regulators around the globe.
Bachelor of Science in Chemical Engineering from Rice University and MBA from Columbia Business School.
2020, US Secretary of Defense awarded the Defense Meritorious Service Medal to Dr. Gerber for exceptionally meritorious service for the Armed Forces.
In 2010 David was appointed by the Secretary of the Department of Health and Human Services (HHS) to the Advisory Committee on Transplantation.